Risk factors for opportunistic infections in patients with inflammatory bowel disease.

By Murat Toruner, E. Loftus, W. Harmsen, A. Zinsmeister, R. Orenstein, W. Sandborn, J. Colombel, LAURENCE J. Egan. Gastroenterology, 2008

1,040 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/a93d99723a84b96b744da46ce539f6e6a36acaea

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. J. Colombel

In Genetics

1. J. Colombel

Citations in the corpus

• Guidelines for the management of inflammatory bowel disease in adults (2011, background): “demonstrated that the respective use of corticosteroids, immunosuppressives or infliximab conferred a threefold increased risk of developing an opportunistic infection that increased to 15-fold when two or more therapies are used in combination.”
• Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee (2010, background): “The use of steroids in IBD increases the risk of opportunistic infections about threefold: the risk is dose related and more common in those over the age of 50 (”
• Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. (2012, background): “orticosteroids between 12 and 6 mo before baseline, n (%) 8 (7)”